Form Type: 4

SEC EDGAR Link
Accession Number:0001179110-19-001906
Date:2019-02-12
Issuer: MOMENTA PHARMACEUTICALS INC (MNTA)
Original Submission Date:

Reporting Person:

FIER IAN
C/O MOMENTA PHARMACEUTICALS, INC.
301 BINNEY STREET CAMBRIDGE, MA 02142

Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
Title of SecurityTransaction Date2a. Deemed Execution Date Transaction CodeSharesAcquired or DisposedPrice per share 5. Amount of Securities Beneficially Owned Following Reported Transaction 6. Ownership Form Direct or IndirectNature of Indirect Ownership
COMMON STOCK 2019-02-12 M 17,500 a $0.00 97,820 direct
COMMON STOCK 2019-02-13 S 5,453 d $12.70 92,367 direct
Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, convertible securities
Title of Derivative Security Conversion or Exercise Price of Derivative Security Transaction Date Deemed Execution Date Transaction Code Number of Derivative Securities Acquired (A) or Disposed of (D) Date ExercisableExpiration Date Title and Amount of Securities Underlying Derivative Security Price of Derivative Security Number of derivative Securities Beneficially Owned Following Reported Transaction(s) Ownership Form: Direct (D) or Indirect (I) Nature of Indirect Beneficial Ownership
RESTRICTED STOCK UNITS 0.0 2019-02-12 deemed execution date M 17,500 (d) common stock 17,500 $0.00 17,500 direct
Footnotes
IDfootnote
f1 shares received pursuant to settlement of restricted stock units that were granted on february 12, 2018.
f2 this transaction was effected pursuant to a rule 10b5-1 trading plan.
f3 restricted stock units convert into common stock on a one-for-one basis.
f4 subject to the officer's continued employment with the company, the restricted stock units will vest with respect to 50% of the shares on the first anniversary of the grant date, and the remaining 50% will vest on the second anniversary of the grant date.
WhaleWisdom Logo

Elevate your investments